NCT06206525Completed
Feasibility Trial Using an Inpatient Insulin Dosing Calculator
Feasibility Trial Using an Insulin Dosing Calculator for Patients With Type 2 Diabetes Mellitus on Hospital Admission
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are: * Whether using this calculator leads to no excessive hypoglycemia? * Whether using this calculator leads to a decrease of hyperglycemia? Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 4 Jan 2024
- Start date
- 22 Mar 2024
- Primary completion date
- 31 May 2025
- Lead sponsor
- University of Washington
- Diseases
- Type 2 diabetes
- NCT number
- NCT06206525
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 22 Mar 2024 to the primary completion date, 31 May 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are admitted for elective surgery or procedure
- Patients who have no meal intake for 24 hours prior to admission, or planned nothing per oral (NPO) during the first 24 hours after admission
- Patients who develop severe acute kidney injury needing dialysis therapy
Other
- Patients who are admitted to ICU or obstetrics ward
- Patients who present with diabetic ketone acidosis, hyperosmolar hyperglycemic state or require intravenous insulin infusion
- Patients who report low appetite (25% or less) on admission or have a significantly decreased level of consciousness that study team does not think they are going to eat right after admission
- Patients who receive enteral feeding after admission
Who the study is looking for
- Patients who are admitted to University of Washington Medical Centers
- With history of type 2 and/or steroid-induced diabetes mellitus
- Receiving insulin therapy prior to admission
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Harborview Medical Center Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
| UW Medical Center - Montlake Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
| UW Medical Center - Northwest Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.